Continuation versus discontinuation of intravenous oxytocin in the active phase of labour

Sidsel Boie; Niels Uldbjerg; Pınar Bor; Jim Thornton; Irene M. de Graaf; Camille Le Ray; Julie Glavind; François Goffinet; Aude Girault

doi:10.1002/14651858.cd015995

November 29, 2024Cochrane libraryOpen Access

Continuation versus discontinuation of intravenous oxytocin in the active phase of labour

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to evaluate the outcomes of stopping intravenous oxytocin during the active phase of labour.
Cochrane Review protocol focusing on intervention studies
Comparative analysis of outcomes related to oxytocin use during labour
Inclusion of pregnant women undergoing induced or augmented labour
Expected to summarize effects of oxytocin discontinuation on labour progress
Will assess safety and effectiveness of this intervention on maternal and fetal outcomes
Findings will guide clinical practices regarding oxytocin use in labour

Implication

Protocol assesses effects of oxytocin discontinuation on labour outcomes in pregnant women, suggesting implications for management practices.

Abstract

OBJECTIVES: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of discontinuing intravenous oxytocin stimulation in pregnant women during the active phase of induced or augmented labour.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Boie et al. (2024) studied this question.

synapsesocial.com/papers/6a61608fcc82e3daa43f71c1 https://doi.org/10.1002/14651858.cd015995

View Full Paper

Ask AI

Bookmark

Share

Continuation versus discontinuation of intravenous oxytocin in the active phase of labour

Key Points

Implication

Abstract

Discussion

Cite This Study

Continuation versus discontinuation of intravenous oxytocin in the active phase of labour

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading